1Pol S, Nalpas B, Driss F,et al. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B [ J ]. J Hepatol,2001,34(6) :917-921.
2Yang BF,Zhao HL,Xue C, et al. Recombinant heat shock protein 65 carrying hepatitis B core antigen induces HBcAg-specific CTL response [ J ]. Vaccine,2007,25 ( 22 ) : 4478-4486.
3Horiike N, Fazle Akbar SM, Michitaka K, et al. In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B[JJ. J Clin Virol,2005,32(2):156-161.
4Ishikawa T, Kakumu S. Use of hepatitis B vaccine for the treatment of chronic hepatitis B [ J ]. Hepatol Res, 2007,37 Suppl 3 : S347-350.
5Ishikawa T, Kakumu S. Combination therapy with lamivudine and HB vaccine on chronic hepatitis B [ J]. Hepatol Res ,2007,37 ( sl ) : S62-66.
6Aziz A, Aziz S, Li DS, et al. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease[J]. J Viral Hepat, 2006,13(4) :217-21.
